Skip to main content

Encapsulating Synthetic STING Agonist, MSA-2, in Endosomolytic Polymersomes for Cancer Immunotherapy

Utilization of STING agonist MSA-2 encapsulated nanocarriers to enhance the immune system’s ability to eliminate cancer cells.

Posted by buchanle on Wednesday, June 25th, 2025 in May 2025, , , , , ,

Read more


Synthesis and Characterization of Macromolecular Polymeric STING Agonists for Cancer Immunotherapy Applications

Incorporating STING agonists into polymeric delivery systems as an alternative cancer treatment.

Posted by buchanle on Tuesday, April 30th, 2024 in May 2024, , , ,

Read more